Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FYBGB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,469
Award facts
- Contract value 100% obligated
- $6,468.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,468.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 200 unit vials. The delivery order, issued on October 27, 2025, carries an ultimate completion date of November 18, 2025, and was made without a set-aside designation, reflecting the contractor's ability to compete in unrestricted federal procurement. This award represents one of numerous recent delivery orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The underlying indefinite delivery contract, designated SPE2DR and awarded on November 13, 2025, carries a $499.9 billion ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance across diverse therapeutic categories and product lines positions it as a critical supplier within the federal military medical system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FYBGB?
SPE2DB26FYBGB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FYBGB worth?
The government has obligated $6,469 on SPE2DB26FYBGB.
Is contract SPE2DB26FYBGB an order under another contract?
Yes. SPE2DB26FYBGB is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB26FYBGB competed?
The extent of competition for SPE2DB26FYBGB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award